ReviewCureus2025
Intraosseous Lipoma of the Calcaneus: A Systematic Review of Reported Cases, Imaging Characteristics, and Treatment Outcomes.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraosseous lipoma (IOL) of the calcaneus is a rare benign tumor composed of mature adipose tissue that may undergo fat necrosis and calcification. Because its imaging features can overlap with other radiolucent bone lesions, calcaneal IOL is sometimes misclassified and may prompt biopsy or surgical intervention for definitive diagnosis. To better characterize this entity, we conducted a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and performed a comprehensive PubMed search using the terms "intraosseous lipoma", "calcaneus", and "heel bone". Eligible studies included case reports and series published between January 1976 and May 2024 that confirmed IOL of the calcaneus through histopathology. A total of 27 studies met criteria, representing 36 patients with a mean age of 40.3 years and a male predominance of 58.3%. Most cases were discovered incidentally or presented with mild heel pain. Imaging typically demonstrated well-defined lytic lesions with central calcification or fat attenuation, and histopathologic descriptions generally aligned with Milgram Stage I or II, though the staging system was not consistently reported. Surgical curettage was performed in 72.2% of patients, while 27.8% were managed conservatively. No malignant transformation or recurrence was reported. Calcaneal IOL should remain in the differential diagnosis for radiolucent heel lesions, and awareness of its characteristic imaging features may reduce unnecessary invasive procedures. While surgery is often chosen for symptomatic cases, conservative management is reasonable for incidental findings. Further research is needed to establish standardized diagnostic and treatment guidelines for this uncommon lesion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.